|
ZCCHC3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.60407999999501E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.434100E-04 |
| Normal-vs-Stage2 |
1.793600E-01 |
| Normal-vs-Stage3 |
4.06930000029782E-07 |
| Normal-vs-Stage4 |
1.5806499999993E-05 |
| Stage1-vs-Stage2 |
3.630200E-01 |
| Stage1-vs-Stage3 |
2.990300E-02 |
| Stage1-vs-Stage4 |
5.754300E-02 |
| Stage2-vs-Stage3 |
1.530410E-02 |
| Stage2-vs-Stage4 |
1.995800E-02 |
| Stage3-vs-Stage4 |
7.829800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.60980999999172E-05 |
| Normal-vs-AfricanAmerican |
1.588020E-01 |
| Normal-vs-Asian |
3.233900E-02 |
| Caucasian-vs-AfricanAmerican |
5.839000E-01 |
| Caucasian-vs-Asian |
1.485190E-01 |
| AfricanAmerican-vs-Asian |
8.153000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.019970E-04 |
| Normal-vs-Female |
3.77540000000565E-05 |
| Male-vs-Female |
6.975000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.796400E-04 |
| Normal-vs-Age(41-60Yrs) |
1.171620E-04 |
| Normal-vs-Age(61-80Yrs) |
9.835300E-04 |
| Normal-vs-Age(81-100Yrs) |
1.262790E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.535400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.144600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.124200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.304800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.274000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.692000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.35109999999106E-06 |
| Classical-VS-Follicular |
3.980400E-01 |
| Classical-VS-Other |
5.615800E-01 |
| Classical-VS-Normal |
3.221000E-04 |
| Tall-VS-Follicular |
3.12930000001543E-06 |
| Tall-VS-Other |
7.580000E-02 |
| Tall-VS-Normal |
1.00240038491961E-10 |
| Follicular-VS-Other |
7.911600E-01 |
| Follicular-VS-Normal |
4.057600E-02 |
| Other-VS-Normal |
6.547600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.803300E-04 |
| Normal-vs-N1 |
5.3786999998362E-07 |
| N0-vs-N1 |
1.688290E-02 |
|
|
